ConductScience.org, home

Comparison · NCT04807101-cd78d951

Midazolam and Fentanyl vs Midazolam Alone: Cecal Intubation Rate

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Midazolam and Fentanyl vs Midazolam Alone: Cecal Intubation Rate. Trial comparisons, record NCT04807101-cd78d951. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04807101-cd78d951

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 110.9751wilson
Risk in group 210.9751wilson
Risk difference, group 1 minus group 20-0.02460.0253newcombe hybrid score
Risk ratio, group 1 over group 2111log
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treatfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Midazolam and FentanylPatients in this arm will receive standard conscious sedation with midazolam and fentanyl152152OG000
Group 2Midazolam AlonePatients in this arm will receive conscious sedation with medazepam alone~midazolam alone: elimination of fentanyl from conscious sedation148148OG001

Outcome

Type
SECONDARY
Title
Cecal Intubation Rate
Description
cecal intubation rate for the 2 arms of the study will be assessed by retrospective chart review
Time frame
through study completion, an average of 1 year
Population

Source ClinicalTrials.gov

Trial

Title
Sedation Regimens in GI Endoscopy
NCT number
NCT04807101
Phases
EARLY_PHASE1
Conditions
Anesthesia, Endoscopy, Colonoscopy, Conscious Sedation
Interventions
midazolam alone
Lead sponsor
Greg S Cohen MD LLC
Results first posted
2024-04-15

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04807101-cd78d951